… Anti-thyroglobulin antibodies (TgAb) can be used as a surrogate tumor marker in the follow-up
of papillary thyroid carcinoma (PTC). We try to determine if the change in TgAb levels in …

… in papillary thyroid carcinoma (PTC). However, the cutoff value of FNA-Tg in the
preoperative state is not defined clearly. This study aimed to evaluate the optimal cutoff value of …

… The aim of this study was to determine the factors that influence long-term disease-specific
survival and thyroglobulin levels in patients with DTC who have been previously treated with …

… Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the
ablative/therapeutic 131 I in the differentiated thyroid cancers. Endocr Res. 2017;42:42–8. …

… absence of other evidence of papillary thyroid carcinoma are common. This pattern will
usually be observed in patients who have a low-risk type of carcinoma and who will be unlikely to …

… papillary thyroid cancer. CLND central lymph node dissection, LLND lateral lymph node
dissection, PTC papillary thyroid cancer, NED no evidence of disease, Tg thyroglobulin …

… FNA thyroglobulin levels in patients and control subjects. The y-axis has a logarithmic
scale. The dotted-line represents the detection limit for Tg in this method (1 ng/ml or 1 ng/FNA …

… diseases and are insensitive and nonspecific for thyroid cancer, their current application is
… evaluation of patients with residual thyroid tissue (3,4). Papillary thyroid carcinoma (PTC) is …

… Some clinicians, however, favor lobectomy or near total thy¬ roidectomy for patients with
papillary thyroid cancer because of the relatively benign behavior of this tumor in low risk …

… We studied early clinical outcomes for papillary thyroid carcinoma (PTC) patients who received
total thyroidectomy and the first HI-Rx to investigate the clinical importance of preablation …